1000818

Abirateronacetat

United States Pharmacopeia (USP) Reference Standard

• Synonym(e): 17-(Pyridin-3-yl)-androsta-5,16-dien-3β-yl-acetat
• Empirische Formel (Hill-System): C₂₆H₃₃NO₂
• CAS-Nummer: 154229-18-2
• Molekulargewicht: 391.55
• MDL-Nummer: MFCD00934213
• UNSPSC-Code: 41116107
• PubChem Substanz-ID: 329748877
• NACRES: NA.24

Eigenschaften

• Qualität: pharmaceutical primary standard
• API-Familie: abiraterone
• Hersteller/Markenname: USP
• Anwendung(en): pharmaceutical (small molecule)
• Format: neat
• SMILES String: C[C@]12C(C[C@@H](OC(C)=O)CC2)=CC[C@]3([H])[C@]1([H])CC[C@@]4(C)[C@@]3([H])CC=C4C5=CC=CN=C5
• InChI: 1S/C26H33NO2/c1-17(28)29-20-10-12-25(2)19(15-20)6-7-21-23-9-8-22(18-5-4-14-27-16-18)26(23,3)13-11-24(21)25/h4-6,8,14,16,20-21,23-24H,7,9-13,15H2,1-3H3/t20-,21-,23-,24-,25-,26+/m0/s1
• InChIKey: UVIQSJCZCSLXRZ-UBUQANBQSA-N
• Angaben zum Gen: human ... CYP17A1(1586)

Beschreibung

Allgemeine Beschreibung

Abiraterone acetate is a pro-drug of abiraterone and a potent inhibitor of the enzyme CYP17, required for androgen biosynthesis in the adrenal glands, testes and prostate tissue.

Anwendung

Abiraterone acetate USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Abiraterone Acetate Tablets

Hinweis zur Analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Sonstige Hinweise

Sales restrictions may apply.

Sicherheitshinweise

• Piktogramme: GHS08,GHS09
• Signalwort: Danger
• H-Sätze: H360F,H373,H410
• P-Sätze: P202 - P260 - P273 - P280 - P308 + P313 - P391
• Gefahreneinstufungen: Aquatic Chronic 1 - Repr. 1B - STOT RE 2
• Zielorgane: Endocrine system
• Lagerklassenschlüssel: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable